1,117
Views
11
CrossRef citations to date
0
Altmetric
Clinical Studies

Epidemiology, outcomes and validation of RIFLE and AKIN criteria in acute kidney injury (AKI) in critically ill patients: Indian perspective

, , , , &
Pages 831-837 | Received 13 Sep 2013, Accepted 23 Feb 2014, Published online: 01 Apr 2014

Figures & data

Table 1. Baseline characteristics of study patients (n = 242).

Figure 1. (a) Epidemiology of AKI (RIFLE criteria). (b) Epidemiology of AKI (AKIN criteria).

Figure 1. (a) Epidemiology of AKI (RIFLE criteria). (b) Epidemiology of AKI (AKIN criteria).

Figure 2. (a) Survival of patients with and without AKI (RIFLE criteria). (b) Survival of patients with and without AKI (AKIN criteria).

Figure 2. (a) Survival of patients with and without AKI (RIFLE criteria). (b) Survival of patients with and without AKI (AKIN criteria).

Table 2. Characteristics of patients with and without AKI (RIFLE Criteria).

Table 3. Characteristics of patients with and without AKI (AKIN Criteria).

Table 4. Predictors of mortality.

Table 5. Comparison of patients having AKI based on RIFLE and AKIN.

Figure 3. ROC curves of APACHE III and severity of AKI. AUC for ROC for APACHE III = 0.815 (p < 0.001), for RIFLEmax = 0.812 (p < 0.001), and for AKINmax = 0.809 (p < 0.001).

Figure 3. ROC curves of APACHE III and severity of AKI. AUC for ROC for APACHE III = 0.815 (p < 0.001), for RIFLEmax = 0.812 (p < 0.001), and for AKINmax = 0.809 (p < 0.001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.